Condition

Hemangioma clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Hemangioma clinical trials that are recruiting, at sites in 2 countries (most in United States (2), South Korea (1)). 1 was first registered in the last 30 days. By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Hemangioma clinical trials

StudyPhaseWhereStatusRegistered
AI tool helps dermatologists decide if a skin lesion could be melanoma Phase 3 Stanford, California and 7 other locations Recruiting Oct 22, 2026
Fluctuational ultrasound imaging to help diagnose liver hemangioma — Seoul, Seodaemun-gu Recruiting Feb 18, 2026
Comparing pulsed dye laser and timolol for treating hemangiomas in newborns — Boston, Massachusetts Recruiting Jun 7, 2013

All recruiting trials (3)

Related topics

Melanocytic NeviMelanoma in Situ

Quick answers

How many Hemangioma clinical trials are recruiting right now?

3, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (2 trials), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.